{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T11:58:10Z","timestamp":1781179090036,"version":"3.54.1"},"reference-count":17,"publisher":"Scientific Scholar","issue":"02","license":[{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"vor","delay-in-days":175,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["South Asian J Cancer"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Background Prognosis of metastatic colorectal cancer (mCRC) is poor and goal of treatment is mainly palliative unless there is limited metastatic disease which is surgically resectable. Here, we report a case series of long-term survivors treated predominantly with chemotherapy.<\/jats:p>\n                  <jats:p>Methods This is a single-center retrospective analysis of patients of mCRC. Records of metastatic colorectal cancer patients registered at Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, between the year 2005 and 2015 were retrieved and reviewed. Inclusion criteria were patients who survived 5 years or more, treated mainly by chemotherapy, with either initial presentation as metastatic disease or those who progressed after initial surgery with or without adjuvant therapy. The details about the patient characteristics, treatment, and outcome were collected. The data were censored on September 30, 2020.<\/jats:p>\n                  <jats:p>Results Records of 370 mCRC patients were reviewed. Thirty-one patients with all the available details fulfilled the criteria for inclusion in the study. Median age was 53 years (range, 22\u201374 years). Sixteen were women (51.6%). Twenty-four (77%) were newly diagnosed cases with initial presentation as metastatic disease. Commonest site of primary was on the left (21, 67.6%) followed by right side and transverse colon in 5 patients each. Liver was the most common site of metastasis (n = 18, 58.06%). In metastatic setting, the most common chemotherapy regimen used in the first line was CAPOX (n = 11, 35.48%). Only three patients could undergo metastatectomy. Monoclonal antibodies could be used only in 14 patients. Median overall survival (OS) of this cohort is 81.6 months (95% confidence interval [CI], 69.73\u2013117.9).<\/jats:p>\n                  <jats:p>Conclusion A small but significant proportion of mCRC patients may achieve and maintain durable responses and long term survival with use of combination of chemotherapy with or without biologics.<\/jats:p>","DOI":"10.1055\/s-0041-1736343","type":"journal-article","created":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T22:33:27Z","timestamp":1632436407000},"page":"87-91","source":"Crossref","is-referenced-by-count":4,"title":["Long-Term Survivors of Metastatic Colorectal Cancer: A Tertiary Care Centre Experience"],"prefix":"10.25259","volume":"10","author":[{"given":"Aparna","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SVS","family":"Deo","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushmita","family":"Pathy","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NK","family":"Shukla","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja","family":"Pramanik","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Raina","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Thulkar","sequence":"additional","affiliation":[{"name":"Department of Radiodiagnosis, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BK","family":"Mohanti","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2021,9,23]]},"reference":[{"issue":"02","key":"ref2","first-page":"653","article-title":"Predictors of survival in stage IV metastatic colorectal cancer","volume":"30","author":"M Zacharakis","year":"2010","journal-title":"Anticancer Res"},{"issue":"02","key":"ref3","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4254\/wjh.v11.i2.150","article-title":"Colorectal liver metastases: an update on multidisciplinary approach","volume":"11","author":"FC-L Chow","year":"2019","journal-title":"World J Hepatol"},{"issue":"16","key":"ref4","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1200\/JCO.2013.49.4500","article-title":"Treatment of metastatic colon cancer: \u201cthe times they are A-changing\u201d","volume":"31","author":"N E Kemeny","year":"2013","journal-title":"J Clin Oncol"},{"issue":"06","key":"ref5","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ctrv.2012.12.011","article-title":"Targeted therapy in metastatic colorectal cancer\u2014an example of personalised medicine in action","volume":"39","author":"V Heinemann","year":"2013","journal-title":"Cancer Treat Rev"},{"issue":"02","key":"ref6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0248-8663(03)00214-5","article-title":"Long term survival in metastatic colorectal cancer treated with leucovorin and 5-fluoro-uracil chemotherapy","volume":"25","author":"N Perez","year":"2004","journal-title":"Rev Med Interne"},{"issue":"35","key":"ref7","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1200\/JCO.2008.17.7147","article-title":"Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741","volume":"26","author":"H K Sanoff","year":"2008","journal-title":"J Clin Oncol"},{"issue":"03","key":"ref8","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/SLA.0b013e31819a0486","article-title":"Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil\/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases","volume":"249","author":"G Masi","year":"2009","journal-title":"Ann Surg"},{"issue":"03","key":"ref9","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.clcc.2011.03.023","article-title":"Durable complete responses in metastatic colorectal cancer treated with chemotherapy alone","volume":"10","author":"R Ferrarotto","year":"2011","journal-title":"Clin Colorectal Cancer"},{"issue":"02","key":"ref10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3816\/CCC.2009.n.014","article-title":"Long-term survivors of metastatic colorectal cancer treated with systemic chemotherapy alone: a north central cancer treatment group review of 3811 patients, n0144","volume":"8","author":"G K Dy","year":"2009","journal-title":"Clin Colorectal Cancer"},{"issue":"22","key":"ref11","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1200\/JCO.2008.20.5278","article-title":"Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy","volume":"27","author":"S Kopetz","year":"2009","journal-title":"J Clin Oncol"},{"issue":"06","key":"ref12","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1023\/A:1008347829017","article-title":"Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery","volume":"10","author":"S Giacchetti","year":"1999","journal-title":"Ann Oncol"},{"issue":"03","key":"ref13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4103\/2278-330X.114152","article-title":"Metastatic colorectal cancer-prolonging overall survival with targeted therapies","volume":"2","author":"S Dattatreya","year":"2013","journal-title":"South Asian J Cancer"},{"issue":"04","key":"ref14","doi-asserted-by":"crossref","first-page":"264","DOI":"10.14740\/gr1062w","article-title":"Difference between left-sided and right-sided colorectal cancer: a focused review of literature","volume":"11","author":"B Baran","year":"2018","journal-title":"Gastroenterol Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejca.2016.10.007","article-title":"The relevance of primary tumour location in patients with metastatic colorectal cancer: a meta-analysis of first-line clinical trials","volume":"70","author":"J W Holch","year":"2017","journal-title":"Eur J Cancer"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1200\/JCO.2013.53.5195","article-title":"Curable patient with metastatic colorectal cancer: balancing effective therapies and toxicities","volume":"32","author":"L oon Van K","year":"2014","journal-title":"J Clin Oncol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"201593","DOI":"10.1155\/2011\/201593","article-title":"Oxaliplatin-induced neuropathy in colorectal cancer [e-pub ahead of print]","volume":"2011","author":"A Weickhardt","year":"2011","journal-title":"J Oncol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4137\/CMO.S5055","article-title":"Long-term treatment of metastatic colorectal cancer with panitumumab","volume":"6","author":"M L\u00f3pez-G\u00f3mez","year":"2012","journal-title":"Clin Med Insights Oncol"}],"container-title":["South Asian Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1736343.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T11:12:25Z","timestamp":1781176345000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.sajc.org\/long-term-survivors-of-metastatic-colorectal-cancer-a-tertiary-care-centre-experience\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":17,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2021,9,23]]},"published-print":{"date-parts":[[2021,4]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1736343","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2278-330X","2278-4306"],"issn-type":[{"value":"2278-330X","type":"print"},{"value":"2278-4306","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}